Cargando…
Should we definitively abandon prophylaxis for patent ductus arteriosus in preterm new-borns?
Although the prophylactic administration of indomethacin in extremely low-birth weight infants reduces the frequency of patent ductus arteriosus and severe intraventricular hemorrhage, it does not appear to provide any long-term benefit in terms of survival without neurosensory and cognitive outcome...
Autores principales: | Fanos, Vassilios, Pusceddu, Michele, Dessì, Angelica, Marcialis, Maria Antonietta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226612/ https://www.ncbi.nlm.nih.gov/pubmed/22189742 http://dx.doi.org/10.1590/S1807-59322011001200022 |
Ejemplares similares
-
Paracetamol in Patent Ductus Arteriosus Treatment: Efficacious and Safe?
por: Bardanzellu, Flaminia, et al.
Publicado: (2017) -
Early Urinary Metabolomics in Patent Ductus Arteriosus Anticipates the Fate: Preliminary Data
por: Bardanzellu, Flaminia, et al.
Publicado: (2020) -
Echocardiographic Evaluation of Patent Ductus Arteriosus in Preterm Infants
por: Arlettaz, Romaine
Publicado: (2017) -
Isoprostanes as Biomarker for Patent Ductus Arteriosus in Preterm Infants
por: Coviello, Caterina, et al.
Publicado: (2020) -
Editorial: Management of Patent Ductus Arteriosus in Preterm Infants
por: Atasay, Begüm, et al.
Publicado: (2021)